HealthEquity EVP sells 1,500 HQY shares at $92.07 under 10b5-1
HealthEquity (HQY) reported an insider stock transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
HealthEquity (HQY) reported an insider stock transaction. The company’s EVP and General Counsel sold 1,500 shares of common stock at $92.07 per share on 10/20/2025.
The sale was executed under a Rule 10b5-1 trading plan adopted on June 12, 2025. Following this transaction, the reporting person beneficially owns 76,979 shares, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,500 | $92.07 | $138K |
Footnotes (1)
- F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did HQY disclose on Form 4?
Was the HQY insider sale under a Rule 10b5-1 plan?
Who is the HQY insider involved in the Form 4?
What was the transaction code reported?
What is the ownership form of the reported HQY holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.